1. Academic Validation
  2. BP5 alleviates endotoxemia-induced acute lung injury by activating Nrf2 via dual regulation of the Keap1-Nrf2 interaction and the Akt (Ser473)/GSK3β (Ser9)/Fyn pathway

BP5 alleviates endotoxemia-induced acute lung injury by activating Nrf2 via dual regulation of the Keap1-Nrf2 interaction and the Akt (Ser473)/GSK3β (Ser9)/Fyn pathway

  • Free Radic Biol Med. 2022 Oct 19;S0891-5849(22)00930-3. doi: 10.1016/j.freeradbiomed.2022.10.299.
Tianxiang Li 1 Zhirong Geng 2 Ju Zhang 3 Lu Xu 4 Xiaoli Zhu 5
Affiliations

Affiliations

  • 1 Department of Pulmonary Medicine, Zhongda Hospital, School of Medicine, South-east University, Nanjing, China. Electronic address: litianxiang96@163.com.
  • 2 State Key Laboratory of Coordination Chemistry, School of Chemistry and Chemical Engineering, Nanjing University, Nanjing, China. Electronic address: gengzr@nju.edu.cn.
  • 3 Wuhan Yangene Biological Technology Co, LTD, Yuechuang Center of HuaZhong Agricultural University, Wuhan, China. Electronic address: 15337192895@163.com.
  • 4 Department of Pulmonary Medicine, Zhongda Hospital, School of Medicine, South-east University, Nanjing, China. Electronic address: xl1807501296@126.com.
  • 5 Department of Pulmonary Medicine, Zhongda Hospital, School of Medicine, South-east University, Nanjing, China. Electronic address: zhuxiaoli@seu.edu.cn.
Abstract

Oxidative stress and inflammation play a crucial role in the pathogenesis of acute lung injury (ALI). Previously, pentapeptide bursopentin (BP5, Cys-Lys-Arg-Val-Tyr) was reported to possess significant antioxidant activity and inhibit lipopolysaccharides (LPS)-induced NF-κB activation in vitro, whereas little is known about its effects in vivo. In this study, we explored the effects of BP5 on endotoxemia-induced ALI in mice and the underlying molecular mechanisms. Our studies revealed that BP5 markedly improved survival and effectively alleviated lung injury by reducing overoxidation and excessive inflammatory response in endotoxemia mice. In LPS-stimulated mouse primary macrophages and RAW 264.7 cells, BP5 also exhibited antioxidant and anti-inflammatory properties by enhancing Nrf2 activation. Importantly, these beneficial effects were abolished by Nrf2 knockdown. To further elucidate the underlying mechanisms, we performed localized surface plasmon resonance (LSPR) assays, molecular docking, together with cell-based studies, and found that BP5 inhibited the Keap1-Nrf2 interaction to promote Nrf2 nuclear translocation and activation. Moreover, BP5-induced Nrf2 activation was shown to be accompanied by an increase in the phosphorylation of Akt (at Ser473) and GSK3β (at Ser9), and a decrease in Fyn nuclear accumulation both in vitro and in vivo. Pharmacologically inhibiting phosphorylation of Akt and GSK3β obviously enhanced Fyn nuclear accumulation in RAW 264.7 cells, which partially attenuated the promoting effect of BP5 on Nrf2 nuclear accumulation and activation. Furthermore, In Nrf2-/- mice, the protective effects of BP5 on the endotoxemia-induced ALI in WT mice were largely vanished. Our findings indicated that BP5 effectively protected endotoxemia-induced ALI against oxidative stress and inflammatory response, which are largely dependent on activation of the Nrf2 pathway. Underlying mechanisms include dual regulation of the Keap-Nrf2 interaction and the Akt (Ser473)/GSK3β (Ser9)/Fyn pathway.

Keywords

Acute lung injury; Akt (Ser473)/GSK3β (Ser9)/Fyn; Inflammation; Keap1-Nrf2 interaction; Nrf2; Oxidative stress.

Figures
Products